Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Medpace Holdings, Inc. - Common Stock
(NQ:
MEDP
)
321.06
+7.20 (+2.30%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 1, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Medpace Holdings, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
Next >
Reflecting On Drug Development Inputs & Services Stocks’ Q1 Earnings: Medpace (NASDAQ:MEDP)
June 24, 2025
Let’s dig into the relative performance of Medpace (NASDAQ:MEDP) and its peers as we unravel the now-completed Q1 drug development inputs & services earnings season.
Via
StockStory
1 Cash-Producing Stock on Our Watchlist and 2 to Think Twice About
June 23, 2025
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.
Via
StockStory
Topics
Intellectual Property
2 Reasons to Watch MEDP and 1 to Stay Cautious
June 18, 2025
Over the last six months, Medpace’s shares have sunk to $293, producing a disappointing 11.5% loss - a stark contrast to the S&P 500’s 1.7% gain. This may have investors wondering how to approach the...
Via
StockStory
Topics
Stocks
2 Small-Cap Stocks to Keep an Eye On and 1 to Think Twice About
June 16, 2025
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a...
Via
StockStory
Insights into Medpace Hldgs's Upcoming Earnings
April 18, 2025
Via
Benzinga
3 Market-Beating Stocks to Target This Week
June 11, 2025
Companies that consistently increase their sales, margins, or returns on capital are usually rewarded with the best returns, and those that can do all three for years on end are almost always the...
Via
StockStory
2 Profitable Stocks to Target This Week and 1 to Turn Down
June 05, 2025
A company with profits isn’t always a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.
Via
StockStory
Is Medpace Stock Worth the Hype? Here's What Analysts Think.
May 27, 2025
Via
The Motley Fool
2 Unpopular Stocks that Deserve Some Love and 1 to Turn Down
May 22, 2025
Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can...
Via
StockStory
Hedge Funds Are Building A Towering Wall Of Bets Against Stocks
May 21, 2025
After a sharp 23% rebound in the S&P 500 since April, hedge funds are now stacking record levels of bearish bets against stocks as investors question the staying power of the tariff-relief rally.
Via
Benzinga
Repligen, Bruker, Agilent, Medpace, and Revvity Shares Skyrocket, What You Need To Know
May 12, 2025
A number of stocks jumped in the afternoon session after the major indices popped (Nasdaq +3.4%, S&P 500 +2.5%) in response to the positive outcome of U.S.-China trade negotiations, as both sides...
Via
StockStory
Topics
Government
Stocks
World Trade
MEDP Q1 Earnings Call: Outperformance Driven by Revenue Upside, Cautious Outlook Amid Funding Uncertainty
May 10, 2025
Clinical research company Medpace Holdings (NASDAQ:MEDP) announced better-than-expected revenue in Q1 CY2025, with sales up 9.3% year on year to $558.6 million. The company’s full-year revenue guidance...
Via
StockStory
Topics
Economy
If A Recession Hits, Will Medical Stocks Be A Safe Haven For Investors — Again?
May 01, 2025
Medical stocks are usually considered defensive. But have they been too hammered by regulatory changes to hold up this year?
Via
Investor's Business Daily
Topics
Animal Testing
Economy
Government
Repligen (RGEN) Q1 Earnings: What To Expect
April 28, 2025
Biopharma manufacturing company Repligen Corporation (NASDAQ:RGEN) will be announcing earnings results tomorrow morning. Here’s what to look for.
Via
StockStory
Topics
World Trade
MEDP Q1 Earnings Call: Revenue Beats Expectations Amid Cancellations and Industry Headwinds
April 24, 2025
Clinical research company Medpace Holdings (NASDAQ:MEDP) announced better-than-expected revenue in Q1 CY2025, with sales up 9.3% year on year to $558.6 million. The company’s full-year revenue guidance...
Via
StockStory
Topics
Earnings
West Pharmaceutical Services Earnings: What To Look For From WST
April 23, 2025
Healthcare products company West Pharmaceutical Services (NYSE:WST) will be reporting results tomorrow before market open. Here’s what investors should know.
Via
StockStory
Topics
Artificial Intelligence
Wall Street Bounces Back As Traders Shake Off Powell Jabs
April 22, 2025
Stocks are higher this afternoon, with all three major indexes bouncing back from Monday’s steep selloff.
Via
Talk Markets
Topics
Stocks / Equities
Why Medpace (MEDP) Stock Is Trading Lower Today
April 22, 2025
Shares of clinical research company Medpace Holdings (NASDAQ:MEDP) fell 11.2% in the pre-market session after the company reported first-quarter 2025 earnings with high expectations heading into the...
Via
StockStory
Medpace Hits 17-Month Low After Bookings Miss Leaves Investors Mystified
April 22, 2025
The company's bookings missed expectations for the fifth consecutive quarter. Investors are questioning its "path forward."
Via
Investor's Business Daily
Thermo Fisher (TMO) Reports Earnings Tomorrow: What To Expect
April 22, 2025
Life sciences company Thermo Fisher (NYSE:TMO) will be reporting earnings tomorrow before the bell. Here’s what to expect.
Via
StockStory
12 Health Care Stocks Moving In Monday's After-Market Session
April 21, 2025
Via
Benzinga
Medpace Holdings Reports Q1 Earnings, Shares Move Lower
April 21, 2025
Medpace Holdings reports first-quarter financial results after the market close on Monday. Here's a look at the key metrics from the quarter.
Via
Benzinga
Medpace (NASDAQ:MEDP) Beats Expectations in Strong Q1 But Stock Drops
April 21, 2025
Clinical research company Medpace Holdings (NASDAQ:MEDP) announced better-than-expected revenue in Q1 CY2025, with sales up 9.3% year on year to $558.6 million. The company’s full-year revenue guidance...
Via
StockStory
Earnings Scheduled For April 21, 2025
April 21, 2025
Via
Benzinga
Medpace (MEDP) Q1 Earnings: What To Expect
April 20, 2025
Clinical research company Medpace Holdings (NASDAQ:MEDP) will be announcing earnings results tomorrow after market close. Here’s what you need to know.
Via
StockStory
Topics
Artificial Intelligence
What 5 Analyst Ratings Have To Say About Medpace Hldgs
April 14, 2025
Via
Benzinga
1 Spectacular Growth Stock Down 34% to Buy Hand Over Fist
April 05, 2025
Via
The Motley Fool
Topics
Initial Public Offering
3 Market-Beating Stocks with Solid Fundamentals
April 01, 2025
Companies that consistently increase their sales, margins, or returns on capital are usually rewarded with the best returns, and those that can do all three for years on end are almost always the...
Via
StockStory
1 Healthcare Stock with Solid Fundamentals and 2 to Ignore
March 28, 2025
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But financial performance has lagged recently as players offloaded surplus COVID...
Via
StockStory
Topics
Stocks
This Kraft Heinz Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Monday
March 24, 2025
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.